Unknown

Dataset Information

0

Down-regulation of CD9 by methylation decreased bortezomib sensitivity in multiple myeloma.


ABSTRACT: Bortezomib therapy has been proven successful for the treatment of relapsed and/or refractory multiple myeloma (MM). However, both intrinsic and acquired resistance has already been observed. In this study, we explored the relationship between CD9 expression and bortezomib sensitivity in MM. We found that down-regulation of CD9 by methylation decreased bortezomib sensitivity in multiple myeloma. CD9 expression obviously increased bortezomib sensitivity through inducing apoptosis, significantly inhibiting U266 cells' adhesion to HS-5 and primary bone marrow stromal cells, but increasing U266 cells' adhesion to fibronectin. CD9 expression also significantly inhibited U266 cell migration. The mechanisms may include: the endoplasmic reticulum stress pathway, cell adhesion related signaling pathway and osteoclast differentiation related signaling pathway. Combination therapy with de-methylation reagent 5-Aza-2-deoxycytidine may prove useful to the development of novel strategies for the treatment of bortezomib-resistant MM patients.

SUBMITTER: Hu X 

PROVIDER: S-EPMC4008425 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature

altmetric image

Publications

Down-regulation of CD9 by methylation decreased bortezomib sensitivity in multiple myeloma.

Hu Xiaotong X   Xuan Han H   Du Huaping H   Jiang Hao H   Huang Jinwen J  

PloS one 20140502 5


Bortezomib therapy has been proven successful for the treatment of relapsed and/or refractory multiple myeloma (MM). However, both intrinsic and acquired resistance has already been observed. In this study, we explored the relationship between CD9 expression and bortezomib sensitivity in MM. We found that down-regulation of CD9 by methylation decreased bortezomib sensitivity in multiple myeloma. CD9 expression obviously increased bortezomib sensitivity through inducing apoptosis, significantly i  ...[more]

Similar Datasets

2014-03-13 | GSE55818 | GEO
2014-03-13 | E-GEOD-55818 | biostudies-arrayexpress
| S-EPMC4431824 | biostudies-literature
| S-EPMC10561007 | biostudies-literature
| S-EPMC8891287 | biostudies-literature
2023-10-24 | PXD042004 | Pride
| S-EPMC3597231 | biostudies-literature
| S-EPMC6681380 | biostudies-literature
| S-EPMC4309843 | biostudies-literature
| S-EPMC7073518 | biostudies-literature